Back to results
US 2026/0132121 A1Published application
Inhibitors of ripk2 and medical uses thereof
AssigneeOdyssey Therapeutics, Inc.
InventorsChad VanHuis, Shifeng Pan, Dominik K. Koelmel, Robert Aversa, Clarke Taylor, Marta Wlodarska
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to RIPK2 inhibitors represented by structural formula (I): The disclosure further relates to pharmaceutical composition comprising the RIPK2 inhibitors and methods of treatment of conditions such as inflammatory diseases, autoimmune diseases, granulomatous disease, neurodegenerative disease and cancer.
Claims110
A compound represented by structural formula (I) or a pharmaceutically acceptable salt thereof:
- wherein:
- R1a, R1b, and R1c are each independently selected from H, C1-6 alkyl, halogen, CN, and;
- R2 is H or C1-3 alkyl;
- R3 is selected from S(═O)2R5, halogen, 4- to 10-membered heterocyclyl, 5-12 membered heteroaryl, S(═O)(═NR6)(R7), QR7, C(═O)NR8R9, NH(C═O)R5, CN, NR8R9, P(═O)R8aR9a;
- R4 is selected from H, halogen, C1-6 alkyl, and C1-6 alkoxy;
- R5 is selected from C1-6 alkyl, NR10R11, C3-6 cycloalkyl, and 4- to 10-membered heterocyclyl;
- R6 is selected from H, CN, and C1-6 alkyl;
- R7 is selected from C1-6 alkyl, C3-6 cycloalkyl, and 4- to 10-membered heterocyclyl, 5-12 membered heteroaryl, or
- R6 and R7 taken together with the nitrogen and sulfur atoms to which they are attached form 4- to 10-membered heterocyclyl;
- Q is selected from O, S, —S(═O)—, and —C(═O)—;
- R8 and R9 are each independently selected from H, C1-6 alkyl, C1-6 deuteroalkyl, C3-6 cycloalkyl, and 4- to 10-membered heterocyclyl, or
- R8 and R9 taken together with the nitrogen atom to which they are attached form 4- to 10-membered heterocyclyl;
- R8a and R9b are each independently C1-6 alkyl, or
- R8a and R9a taken together with the phosphorus atom to which they are attached form 4- to 10-membered heterocyclyl;
- R10 and R11 are each independently H or C1-6 alkyl, or
- R10 and R11 taken together with the nitrogen to which they are attached form 4- to 10-membered heterocyclyl;
- W is selected from a bond, O, NR2, O(C1-2 alkylene), NH(C1-2 alkylene), C1-2 alkylene, and C3-6 cycloalkylene;
- X is a moiety represented by one of the following structural formulas:
- Y1 is CH or N;
- Y2 and Y3 are each independently CR4 or N;
- U is CR12b or N;
- Z is CR1b or N;
- L, M, and J are each independently selected from N, O, or S, provided that two of L, M, and J are N;
- R12 is selected from C3-6 alkyl, C3-6 cycloalkyl, C5-12 bridged bicyclic carbocyclyl, and 4- to 10-membered heterocyclyl;
- R12a is selected from C1-6 alkyl, C1-6 deuteroalkyl, C3-6 cycloalkyl, C5-12 bridged bicyclic carbocyclyl, and 4- to 10-membered heterocyclyl;
- R12b and R13 are each independently H or C1-6 alkyl;
- and
- is a single bond or a double bond,
- wherein each C1-6 alkyl, C1-3 alkyl, C1-2 alkylene, C3-6 alkyl, C3-6 cycloalkyl, C1-6 alkoxy, C5-12 bridged bicyclic carbocyclyl, 5-12 membered heteroaryl, and 4- to 10-membered heterocyclyl is optionally substituted with 1 to 3 substituents independently selected from deuterium, oxo, F, Cl, Br, CN, OR14, SR15, NR16R17, S(O)R18, S(O)2R18a, NR19S(═O)R20, C(═O)OR20a, C(═O)NR21R22, NR23C(═O)R24, C(═S)NR25R26, C(═O)R27, C1-6 alkyl, C1-6 deuteroalkyl, C3-8 cycloalkyl, C2-6 alkenyl, halo(C1-6)alkyl, C1-3 alkylsulfonylaminoalkyl, hydroxy(C1-6)alkyl, amino(C1-6)alkyl, (C1-6)alkylamino(C1-6)alkyl, cyano(C1-6)alkyl, C1-3 alkylcarbonylamino(C1-6)alkyl, C1-3 alkoxy, halo(C1-3)alkoxy, C1-6 alkoxy(C1-3)alkyl, C6-12 aryl, 4- to 8-membered heterocyclyl, and 5- to 12-membered heteroaryl, wherein
- R14, R15, R18, R18a, R20, R20a, R24, and R27 are each independently hydrogen or C1-6 alkyl;
- R16 and R17 are each independently selected from hydrogen, C1-6 alkyl, hydroxy(C1-6)alkyl, and halo(C1-6)alkyl;
- R19 and R23 are each independently C1-6 alkyl or halo(C1-6)alkyl;
- R21, R22, R25 and R26 are each independently selected from H, C1-6 alkyl, C1-3 alkoxy(C1-6)alkyl, hydroxy(C1-6)alkyl, cyano(C1-6)alkyl, amino(C1-6)alkyl, C1-3 alkylamino(C1-6)alkyl, and di(C1-3)alkylamino(C1-6)alkyl;
- or
- R21 and R22 or R25 and R26, together with the nitrogen to which they are attached, form a 3-8 membered ring optionally substituted with 1 to 3 substituents independently selected from deuterium, oxo, F, Cl, Br, CN, OR14, SR15, NR16R17, S(O)R18, S(O)2R18a, NR19S(═O)R20, C(═O)OR20a, C(═O)NR21R22, NR23C(═O)R24, C(═S)NR25R26, C(═O)R27, C1-6 alkyl, C3-8 cycloalkyl, C2-6 alkenyl, halo(C1-6)alkyl, C1-3 alkylsulfonylaminoalkyl, hydroxy(C1-6)alkyl, amino(C1-6)alkyl, cyano(C1-6)alkyl, C1-3 alkylcarbonylamino(C1-6)alkyl, C1-3 alkoxy, halo(C1-3)alkoxy, C1-6 alkoxy(C1-3)alkyl, C6-12 aryl, 4- to 10-membered heterocyclyl, and 5- to 12-membered heteroaryl.
- provided that when Y2 is CH substituted with R4 and R4 is optionally substituted C1-6 alkoxy, W—R3 is not CN or optionally substituted C1-6 alkoxy;
- and
- provided that when Y1, Y2 and Y3 are each CH, then W—R3 is not F.
35 more elements
Dependencies are inferred from the claim text.